GlassScriptPhysician profile
Marcel E Zughaib
NPI 1922038488
$256,556.16
in general payments reported to CMS, 2019-2025
50 companies · $3,900 in 2025
The $3,900 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117K · 2020: $9,839 · 2021: $29K · 2022: $43K · 2023: $39K · 2024: $14K · 2025: $3,900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Food and Beverage: $9,829 · Travel and Lodging: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,600.00 |
| Food and Beverage | $9,829.08 |
| Travel and Lodging | $774.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $173,332.07 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $21,520.86 | 2019-2025 | Verquvo |
| Medtronic Vascular, INC. | $19,744.48 | 2019-2020 | |
| Abbott Laboratories | $14,108.51 | 2019-2025 | Amplatzer Amulet, Ensite Precision, Esprit |
| Sanofi-Aventis U.S. LLC | $12,208.91 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $4,746.20 | 2019 | |
| Medtronic, INC. | $1,500.61 | 2021-2025 | Corevalve Evolut R, Protege Rx, Hawkone |
| Amgen INC. | $1,390.43 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $797.16 | 2019-2025 | Lifevest |
| Abiomed | $729.85 | 2022-2025 | Impella |
| Merz North America, INC. | $658.07 | 2021-2024 | Xeomin |
| Kestra Medical Technology Services, INC. | $470.98 | 2024-2025 | Assure Wcd |
| Boston Scientific Corporation | $421.41 | 2020-2025 | Avvigo Guidance System, Rotapro |
| Novartis Pharmaceuticals Corporation | $418.40 | 2019-2025 | |
| Philips North America LLC | $383.37 | 2020-2025 | IV Other |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $378.93 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $336.87 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $324.68 | 2019-2024 | Jardiance |
| Inari Medical, INC. | $321.06 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $277.00 | 2022-2024 | Penumbra System |
| Edwards Lifesciences Corporation | $257.68 | 2019-2025 | Sapien 3 Ultra Resilia |
| Genzyme Corporation | $250.18 | 2019-2023 | |
| Opsens INC. | $217.49 | 2021-2022 | |
| Stryker Corporation | $211.23 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Chiesi USA, INC. | $206.24 | 2025 | Kengreal, Cleviprex |
| Cardiovascular Systems INC. | $167.39 | 2019-2020 | |
| Heartflow, INC. | $157.04 | 2019 | |
| Impulse Dynamics (USA) INC. | $153.07 | 2023-2024 | Optimizer, Optimizer |
| W. L. Gore & Associates, INC. | $134.67 | 2021 | |
| Bracco Diagnostics INC. | $124.96 | 2019 | |
| Siemens Medical Solutions USA, INC. | $112.25 | 2019-2020 | |
| Pfizer INC. | $78.55 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $69.48 | 2024 | Wainua |
| Novo Nordisk INC | $60.23 | 2025 | Wegovy |
| Cardiva Medical, INC. | $47.28 | 2024 | Optowire |
| Kiniksa Pharmaceuticals International, Plc | $35.84 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $34.72 | 2019 | |
| Biotronik INC. | $33.70 | 2021 | |
| Csl Behring | $23.73 | 2019 | |
| Teleflex LLC | $21.09 | 2025 | Guideliner |
| Alnylam Pharmaceuticals INC. | $20.23 | 2025 | Onpattro |
| Cordis US Corp. | $19.45 | 2025 | Mynx Control Venous |
| Mylan Specialty L.P. | $18.77 | 2022 | |
| Astellas Pharma US INC | $16.26 | 2019 | |
| Irhythm Technologies, INC. | $14.78 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcel Zughaib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.